---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-23-001678"
form_type: "8-K"
ticker: "CRL"
cik: "0001100682"
company_name: "CHARLES RIVER LABORATORIES INTERNATIONAL, INC."
filed_at: "2023-11-08T23:59:59+00:00"
generated_at: "2026-06-08T08:38:49.567451+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Charles River Q3 results beat; narrows and raises non-GAAP EPS guidance for 2023

## Summary
- Q3 revenue $1.03B (+3.8% YoY); GAAP EPS $1.69 (-10.1%), non-GAAP EPS $2.72 (+3.4%).
- Organic revenue growth 4.1%, driven by DSA (+5.3% organic) and RMS (+3.2% organic).
- DSA segment GAAP operating margin down to 22.1% from 22.9%; non-GAAP up to 27.2% from 26.2%.
- RMS GAAP op margin 15.2% vs 19.9% prior; Manufacturing op margin down on GAAP and non-GAAP basis.
- FY2023 guidance: organic rev growth 5.5%-6.5% (narrowed from 5.5%-7.5%); non-GAAP EPS $10.50-$10.70 (prior $10.30-$10.90).

## SEC filing metadata
- accession: 0001157523-23-001678
- form_type: 8-K
- ticker: CRL
- cik: 0001100682
- company_name: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- filed_at: 2023-11-08T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1100682/000115752323001678/0001157523-23-001678-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1100682/000115752323001678/a53773748.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-23-001678
- JSON: https://secwatch.observer/filing/0001157523-23-001678.json
- Plain text: https://secwatch.observer/filing/0001157523-23-001678.txt

## Key facts
- Earnings Releases
  CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported the third quarter of 2023 results: revenue $1.03 billion, net income $87.4 million, EPS $1.69. Guidance lowered.
  - Period: the third quarter of 2023
  - Revenue: $1.03 billion
  - Net income: $87.4 million
  - EPS: $1.69
  - Guidance: lowered
  - Result: reported results
  source text: EX-99.1 (EXHIBIT 99.1) --- EX-99.1 2 a53773748ex99_1.htm EXHIBIT 99.1 Exhibit 99.1 Charles River Laboratories Announces Third-Quarter 2023 Results – Third-Quarter Revenue of $1.03 Billion – – Third-Quarter GAAP Earnings per Share of $1.69 and Non-GAAP Earnings per Share of $2.72 – – Updates 2023 Guidance – WILMINGTON, Mass.--(BUSINESS WIRE)--November 8,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1100682/000115752323001678/0001157523-23-001678-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.